Total Funding
51
Total FundingSeed raised
Growth Score in past quarter
pts
Heat Score 51 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
229631
CNSDose provides gene testing service and guides for the proper antidepressant.
- Campbell Walshe: Chief Operating Officer
Ajeet B Singh: Founder & CEO
About the Company
The CNSDose Report - powered by DNA - guides which antidepressant and dose is most appropriate. With world-first understanding of how antidepressants reach the brain, and backed by clinical trial evidence, CNSDose is the first 2nd generation pharmacogenetic report.

